SEC Comment Letter 0000000000-25-003946 to EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC.
Date: April 14, 2025 · CIK: 0001549084 · Accession: 0000000000-25-003946
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286463
Letter
Re: Ekso Bionics Holdings, Inc. Registration Statement on Form S-3 Filed April 10, 2025 File No. 333-286463 Dear Scott Davis:
April 14, 2025
Scott Davis Chief Executive Officer Ekso Bionics Holdings, Inc. 101 Glacier Point, Suite A San Rafael, California 94901
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Mitchell Austin at 202-551-3574 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Technology
cc: Austin March
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 14, 2025 Scott Davis Chief Executive Officer Ekso Bionics Holdings, Inc. 101 Glacier Point, Suite A San Rafael, California 94901 Re: Ekso Bionics Holdings, Inc. Registration Statement on Form S-3 Filed April 10, 2025 File No. 333-286463 Dear Scott Davis: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Mitchell Austin at 202-551-3574 with any questions. Sincerely, Division of Corporation Finance Office of Technology cc: Austin March </TEXT> </DOCUMENT>